Synonyms
Status
Molecule Category UNKNOWN
ATC N06AX07
UNII 00U7GX0NLM
EPA CompTox DTXSID5048477

Structure

InChI Key LDMWSLGGVTVJPG-UHFFFAOYSA-N
Smiles Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1
InChI
InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H22N4O
Molecular Weight 298.39
AlogP 2.2
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 50.28
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 22.0

Bioactivity

Mechanism of Action Action Reference
Acetylcholinesterase inhibitor INHIBITOR PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed
Protein: Muscarinic acetylcholine receptor M1

Description: Muscarinic acetylcholine receptor M1

Organism : Homo sapiens

P11229 ENSG00000168539
Protein: Monoamine oxidase A

Description: Amine oxidase [flavin-containing] A

Organism : Homo sapiens

P21397 ENSG00000189221
Protein: Acetylcholinesterase

Description: Acetylcholinesterase

Organism : Homo sapiens

P22303 ENSG00000087085
Protein: Serotonin 2 (5-HT2) receptor

Description: 5-hydroxytryptamine receptor 2A

Organism : Homo sapiens

P28223 ENSG00000102468
Protein: Serotonin 2 (5-HT2) receptor

Description: 5-hydroxytryptamine receptor 2C

Organism : Homo sapiens

P28335 ENSG00000147246
Protein: Serotonin 2 (5-HT2) receptor

Description: 5-hydroxytryptamine receptor 2B

Organism : Homo sapiens

P41595 ENSG00000135914
Assay Description Organism Bioactivity Reference
Percent Inhibition of trypanothione reductase activity at 28.5 uM concentration Trypanosoma cruzi 16.0 %
Percent Inhibition of trypanothione reductase activity at 5.7 uM concentration Trypanosoma cruzi 18.0 %
Percent Inhibition of trypanothione reductase activity at 57 uM concentration Trypanosoma cruzi 12.0 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 17.29 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.03 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.03 %

Cross References

Resources Reference
ChEBI 51038
ChEMBL CHEMBL278819
DrugBank DB00805
DrugCentral 1812
FDA SRS 00U7GX0NLM
Human Metabolome Database HMDB0014943
PharmGKB PA164748351
PubChem 4199
SureChEMBL SCHEMBL49371
ZINC ZINC000019796082